Patent US9639150 message

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+) Patent US9639150 message

Medlmmune Llc patents

Recent patent applications related to Medlmmune Llc. Medlmmune Llc is listed as an Agent/Assignee. Note: Medlmmune Llc may have other listings under different names/spellings. We're not affiliated with Medlmmune Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Medlmmune Llc-related inventors

Date Medlmmune Llc patents (updated weekly) - BOOKMARK this page
03/02/17Methods of using anti-ang2 antibodies
10/13/16Anti-pseudomonas psl binding molecules and uses thereof
04/28/16Synthetic oligosaccharide subunits of the psl exopolysaccharide of pseudomonas aeruginosa and uses thereof
03/24/16Separation of recombinant polyclonal antibody multimers with minimal separation of monomers
02/04/16Antagonists of pdl-1 and pd-1 for the treatment of hpv-negative cancers
01/28/16Recombinant polypeptide production
12/24/15Respiratory syncytial virus f protien epitopes
12/03/15Liquid antibody formulation with improved aggregation properties
09/10/15Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy
07/09/15Type 1 interferon diagnostic
06/11/15Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies
05/28/15Interferon alpha-induced pharmacodynamic markers and uses thereof
05/14/15Interferon alpha-induced pharmacodynamic markers
04/23/15Antibody production methods
04/09/15Cd40l-specific tn3-derived scaffolds and methods of use thereof
02/12/15Treatment of multiple sclerosis with anti-cd19 antibody
01/02/14Systems and methods for processing requests for pharmaceuticals that require insurer preapproval
03/28/13Fibronectin type iii domain-based multimeric scaffolds
02/28/13Hsa-related compositions and methods of use
12/20/12Stabilized liquid anti-rsv antibody formulations
11/22/12Recombinant parainfluenza virus expression systems and vaccines
11/08/12Functional mutation in respiratory syncytial virus
08/02/12Targeted binding agents directed to dll4 and uses thereof 524
06/21/12Human-murine chimeric antibodies against respiratory syncytial virus
06/14/12Methods of reducing eosinophil levels
06/14/12Humanized anti-cd 19 antibody formulations
05/31/12Influenza hemagglutinin and neuraminidase variants
02/02/12Preservation of bioactive materials by freeze dried foam
11/24/11Interferon alpha-induced pharmacodynamic markers
10/06/11Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
02/10/11Cysteine engineered antibodies for site-specific conjugation
01/13/11Methods of treating rsv infections and related conditions
11/04/10Antibody formulations having optimized aggregation and fragmentation profiles
08/05/10Targeted binding agents directed to dll4 and uses thereof 524
08/05/10Targeted binding agents directed to sonic hedgehog homolog and uses thereof
11/12/09Methods of improving packed-bed chromatography performance
09/03/09Affinity optimized epha2 agonistic antibodies and methods of use thereof
08/20/09Methods of producing influenza vaccine compositions
07/23/09Methods of preventing or treating respiratory conditions
07/09/09Influenza hemagglutinin and neuraminidase variants

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Medlmmune Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Medlmmune Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by